Dual Blockade of CD44v6 and PI3K Undermines Colorectal Cancer Stem Cell Reprogramming
A preclinical study reports that combining the CD44v6 inhibitor AMC303 with the dual PI3K/mTOR inhibitor Apitolisib suppresses HGF-driven reprogramming and ...
A preclinical study reports that combining the CD44v6 inhibitor AMC303 with the dual PI3K/mTOR inhibitor Apitolisib suppresses HGF-driven reprogramming and ...
KIT-led researchers show that inactivating the CD44 molecule reprograms tumor-promoting fibroblasts in pancreatic cancer, reducing fibrosis and immunosuppression and shrinking ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine